Login
Subscribe
News
Agribusiness
Banking & Finance
Columns
Destinations
Energy
Health Care & Life Science
Higher Education
Law & Goverment
Nonprofits
Podcast Charting her course
Real Estate
Small Business
Technology
Regions
Central Coast
East Ventura County
Santa Barbara County
San Luis Obispo County
South Coast
Ventura County
Opinion
Columns
Editorials
Editorial Cartoons
Letters to the Editor
Op/Eds
Lists
Download Lists
Reprints
Nominations
Special Reports
Events
2023 Events
Newsmakers
March 25, 2023
Loading...
You are here:
Home
>
Banking & Finance
>
Current Article
Beyond biologics: Amgen bets new drugs will pay dividend
IN THIS ARTICLE
Banking & Finance
Topic
Henry Dubroff
Author
By
Henry Dubroff
Friday, May 6th, 2011
Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.
This article is only available to Business Times subscribers
Subscribers:
LOG IN
or
REGISTER
for complete digital access.
Not a Subscriber?
SUBSCRIBE
for full access to our weekly newspaper, online edition and Book of Lists.
Check the
STATUS
of your Subscription Account.
Related Articles
Thursday, November 3rd, 2022
Amgen income tops $2B in Q3
Thursday, October 13th, 2022
Amgen shares up amid optimism over experimental weight-loss drug
Friday, September 30th, 2022
At CLU forum, employers are resigned to the new jobs reality
newsletter sign-up
SIGN UP